Conventional taxanes are used as cornerstone of the chemotherapeutical treatment for a variety of malignancies. Nevertheless, a large proportion of patients do not benefit from their treatment while they do suffer from severe adverse events related to the solvent or to the active compound. Cremophor EL and polysorbate 80 free formulations, conjugates, oral formulations and different types of drug delivery systems are some examples of the several attempts to improve the treatment with taxanes. In this review article, we discuss recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer. Targeting mechanisms of drug delivery systems and characteristics of the most commonly used taxane-containing drug delivery systems in the clinical setting will be discussed in this review.

nanomedicine, nanoparticle, drug delivery systems, taxane, cancer
dx.doi.org/10.2147/ijn.S272529, hdl.handle.net/1765/131462
International Journal of Nanomedicine
Department of Medical Oncology

van Eerden, R.A.G., Mathijssen, A.H.J, & Koolen, S.L.W. (2020). Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer. International Journal of Nanomedicine, 15, 8151–8166. doi:10.2147/ijn.S272529